CBG | Jotup

Carofin Closes $2.5MM in Southeast Blueberry Farm Transaction

Retrieved on:

Thursday, July 6, 2023

Farm, Brick, Syndication, CFG, REIT, Agriculture, Aviation, CBG, Sale, Real estate investing, BCM, Traction, Investment, Real estate investment trust, Growth, CFS, SPV, Real estate, Coffee

BREVARD, N.C., July 06, 2023 (GLOBE NEWSWIRE) -- Carofin and Carolina Financial Securities are proud to announce the closing of yet another investment in a blueberry farm in the Southeast, building upon last year’s successful raise for a similar farm.

Key Points:

BREVARD, N.C., July 06, 2023 (GLOBE NEWSWIRE) -- Carofin and Carolina Financial Securities are proud to announce the closing of yet another investment in a blueberry farm in the Southeast, building upon last year’s successful raise for a similar farm.
Funded through the single purpose vehicle (SPV), Berry Capital Management II (BCM II), proceeds from this financing accomplished three objectives.
The financing secured a farm lease with an institutional agricultural Real Estate Investment Trust (REIT), purchased equipment to operate the farm, and provided working capital to prepare the crop for the 2023 harvest.
“Each farm further puts Carolina Berry Group in a position to support our retail customers better as well as our marketing partnerships,” said Brick Rooks, CBG’s CEO.

Significant Increase in Revenue Proving 2023 to be a Banner Year for Hemp, Inc.

Retrieved on:

Wednesday, June 28, 2023

CBDA, Anxiety, Cannabinoid, Absorption, CBG, CBN, Restaurant, OTC, MCT, Cannabis, Coffee, Relaxation, CBGA, News, Hemp, CBD

These are active ingredients in cannabis that are derived from the hemp plant, which is widely known for pain relief, relaxation, and anxiety relief.

Key Points:

These are active ingredients in cannabis that are derived from the hemp plant, which is widely known for pain relief, relaxation, and anxiety relief.
Mixing CBN, CBD, and CBG is a great recipe for a better night’s sleep.
The Company’s CBD, CBDA, CBG, CBGA, and CBN product lines are highly potent therapeutic doses that have received rave reviews.
The Company expects 2023 to be a banner year in terms of generating income.

MariMed’s Betty’s Eddies™ Introduces Limited-Edition THC and CBG Infused Beachtime Betty’s for Summertime Relaxation

Retrieved on:

Thursday, June 22, 2023

CSE, Boston Beer Company, Cannabinoid, Immunity, CBG, Marketing, Vitamin, Fort São Sebastião (Castro Marim), Research, THC, Dietary supplement

BOSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural, cannabis fruit chews handcrafted to fit a variety of needs, has launched a new limited-edition batch of strawberry lemonade chews for the summer: Beachtime Betty’s. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD).

Key Points:

Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD).
Beachtime Betty’s celebrates summer’s iconic flavors by melding tart and refreshing lemonade with real, organic, just-picked strawberries.
Beachtime Betty’s is among O’Malley’s first product launches since joining the company earlier this year after 20+ years with the famed Boston Beer Company.
Made for adult-use and medical consumers, Beachtime Betty’s is currently available exclusively in cannabis dispensaries in Massachusetts and will hit dispensaries in Delaware and Maryland soon.

The Flaming Lips Frontman Wayne Coyne Brings Love Yer Brain Infused Gummy Line Nationwide During The Psychedelic Science 2023 MAPS Benefit Concert and Afterparty

Retrieved on:

Wednesday, June 14, 2023

Love, Music, Yoshimi Battles the Pink Robots, Partnership, The Flaming Lips, Stock, CBG, Creativity, CBN, CO, Brain, MAPS, Happiness, Multidisciplinary Association for Psychedelic Studies, AEG, THC, Grammy Awards, Nightclub, Rest

The Visionary Musician Introduces Adaptogenic Mushroom and Hemp-Infused Gummies to Love Yer Brain's Product Lineup, Increasing Access to Clarity and Calm-Inducing Properties

Key Points:

Joining Love Yer Brain's existing lineup of strain-specific live-resin THC gummies, new varieties Rest and Focus will combine hemp-derived cannabinoids with adaptogenic mushroom ingredients for targeted effects.
The goal of Love Yer Brain has always been to share the power of plant medicines with as many people as possible," said Coyne.
"Love Yer Brain was born to provide consumers an elevated and inspired experience in their everyday lives," said Evan Eneman, CEO and co-founder of Love Yer Brain.
We're confident Love Yer Brain's Focus and Rest will deliver on experience and meet the desires of consumers nationwide where permissible."

BioWellnessX Expands Delta-9 Inventory with Two Powerful THCp Gummies

Retrieved on:

Thursday, June 8, 2023

Tetrahydrocannabiphorol, CBN, Cannabinoid, Health, Gummy candy, Sleep, THC, CBG, Birth control

"We couldn't be more excited to announce the addition of our Delta-9X and Delta-9Z Zen Gummies," said a BioWellnessX representative.

Key Points:

"We couldn't be more excited to announce the addition of our Delta-9X and Delta-9Z Zen Gummies," said a BioWellnessX representative.
"Each new THCp gummy is formulated with 53mg of total cannabinoids, including 3mg of ultra-potent THCp.
Like the rest of their cannabis line, BioWellnessX is committed to creating the cleanest, health-centric THCp gummies: free from harmful pesticides, synthetic chemicals, and other artificial additives.
Here's a closer look at BioWellnessX's new THCp gummies:
To learn more about their THCp Gummies, Click Here .

KND Labs Named 2023 NASC MVP Supplier of the Year

Retrieved on:

Tuesday, May 30, 2023

KND Labs is pleased to announce the company has been named National Animal Supplement Council’s (NASC) MVP Supplier of the Year in 2023 — KND Labs’ second consecutive year receiving this recognition.

Key Points:

KND Labs is pleased to announce the company has been named National Animal Supplement Council’s (NASC) MVP Supplier of the Year in 2023 — KND Labs’ second consecutive year receiving this recognition.
MVP Supplier of the Year is awarded by the NASC Board of Directors each year during the organization’s annual member conference as a way to showcase the supplier most beneficial to its members in the last year.
“KND Labs is thrilled and honored by this continued recognition as the premier supplier of CBD ingredients for pet products,” said KND Labs President Nich Wilson.
“Partnering with a trustworthy CBD supply chain partner is critical for producers of pet supplements and other pet industry products,” said KND Labs Manager of Sales, Courtlandt Pennell.

New The Clear™ Gummy Edible Line DripCees Launches in Colorado; New Mexico Launch to Follow in June

Retrieved on:

Tuesday, May 16, 2023

Cream, CCG, CCI, Cannabinoid, Clear, CBG, CBN, LIT, CBD, Classic, THC, Drug

DripCees Gummies will be available at retail stores across Colorado beginning the week of May 15 and will debut in the New Mexico market in June 2023.

Key Points:

DripCees Gummies will be available at retail stores across Colorado beginning the week of May 15 and will debut in the New Mexico market in June 2023.
DripCees Gummies are infused using premium distillate and enriched with specific ratios of cannabinoids designed to provide distinctive experiences.
“We are very excited to launch DripCees with CCI, which has an established presence in this market,” said CCG Logistics Operations Manager Bonnie Kenny.
DripCees gummies are already gaining industry accolades: The DripCees Strawberry Watermelon Recover 1:1 THC/CBG Gummies recently won second place in the March 2023 THC Classic in Colorado in the “Gummy” category.

Indiva Reports First Quarter 2023 Results

Retrieved on:

Tuesday, May 16, 2023

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.

Key Points:

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.
Baked Goods: Indiva led the baked goods category with 61.0% sub-category share, driven by the success of Indiva Life Double-Stuffed Sandwich Cookies.
Product ranking in Q1 2023 showed two of the Top 10 edible SKUs are from Indiva.
OPERATING AND FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS

Retrieved on:

Friday, May 12, 2023

Food, Bank statement, Sandhill, Active ingredient, CBG, The Company, SEDAR, Drug discovery, Protein engineering, TSX, Growth, WLLW, Biocatalysis, M3, Willow Springs Distilling Company, Willow, Fine chemical, Renewable energy, Cannabigerol

Willow's unaudited consolidated interim financial statements and related management's discussion and analysis for the quarter ended March 31, 2023 are available on SEDAR at www.sedar.com .

Key Points:

Willow's unaudited consolidated interim financial statements and related management's discussion and analysis for the quarter ended March 31, 2023 are available on SEDAR at www.sedar.com .
On February 22, 2023, Willow announced the appointment of Jim Lalonde, Ph.D. as its newest independent member of the Company's Board of Directors, effective February 21, 2023.
Willow ended the quarter with strong liquidity, including approximately $10.5 million of cash as of March 31, 2023, with the Company's approved annual budget expected to be fully funded for 2023.
The Company reported revenue of $274,000 for the quarter compared to nil revenue for the first quarter of 2022.

22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook

Retrieved on:

Tuesday, May 9, 2023

Acceleration, Nonmotorized Transportation Pilot Program, Nicotine, Table, Q&A, Casualty loss, GVB, Policy, Tobacco, CMO, Pacific Century Group, CBG, Sale, Old pal, EBITDA, CDMO, Acquisition, Investment, Pinnacle, Smoke, NASCO, XXII, Growth, Webcast, FSA, Century, Health, FDA, Smoking, Biomass, Adjustment, Cannabidiol, Geography, Real estate, Video game, Beauty salon, Management, Drug, Retail, Oil, EU, CBD

We again reported record cannabinoid ingredient volumes delivered in the first quarter, a trend we expect to further increase throughout 2023.

Key Points:

We again reported record cannabinoid ingredient volumes delivered in the first quarter, a trend we expect to further increase throughout 2023.
“We believe 22nd Century is poised for phenomenal growth this year in both our tobacco and hemp/cannabis businesses.
Operating loss for the first quarter of 2023 was $17.8 million, compared to $8.1 million in the prior year period.
During the webcast, James A. Mish, chief executive officer of 22nd Century Group, John Miller, president of 22nd Century’s tobacco business, and Hugh Kinsman, chief financial officer, will provide an update on the Company.